|
Consultancy.
The ERGOMED Group is a pan-European Clinical Development Company,
providing full clinical trial-related services to developers of
medical drugs. ERGOMED can assist with strategic clinical development
planning, individual study design, project management and monitoring,
study site management, drug safety monitoring and pharmacovigilance,
medical writing as well as data management, biostatistics, regulatory
assistance and other services. In addition, ERGOMED has access
to its own Phase 1 unit for healthy volunteer studies as well as
those in special populations and early phase oncology studies.
With its headquarters in Frankfurt, Germany, and five operational
centres in London, Zagreb, Novi Sad, Krakow, and San Antonio ERGOMED
currently conducts operations in over 20 different European countries.
ERGOMED specialises in oncology, neurology and diabetology while
retaining experience in many other therapeutic areas and indications.
ERGOMED provides clinical development services to some of the
world’s largest pharmaceutical companies as well as to many
small- and mid-sized drug development companies and has been responsible
for the pivotal studies of several drugs including a number of
oncologics which have gone on to receive European regulatory approval.
ERGOMED’s success is due largely to its motivated, highly
trained, experienced and dedicated workforce. In only five years
since its inception, the company has grown to around 90 employees,
one-quarter of whom hold doctorates in medicine or the life sciences.
ERGOMED has never had a trial contract cancelled or suspended,
and has never had an unsatisfied customer; many clients have signed
up for repeat business. In fact, a significant minority of its
contracted opportunities
have come from ‘rescue’ operations, taking over clinical
trial responsibilities from CROs which have not performed according
to project plans or expectations. In addition, a number of referrals
have come from other CROs with which ERGOMED has collaborated,
an important indication of ‘peer certification’. Finally,
ERGOMED has successfully passed all audits performed by its clients
and by independent authorities.
While ERGOMED prides itself on providing services across the spectrum
of the pharmaceutical industry, the company has particular experience
in working with biotech. ERGOMED is well placed to partner emerging
and developing companies in this sector.
|
